Karen Andersen, CFA, of Morningstar shares the firm’s thinking and broader trends shaping the development of coronavirus treatments in an interview with GEN Edge . . .
The post Assessing Coronavirus Impact on Wall Street appeared first on GEN – Genetic Engineering and Biotechnology News.
